Latest Breaking News On - Nancy simonian - Page 1 : vimarsana.com

"Restore trust and get Bayer on track for better performance" - Three-year process of rejuvenation launched

In 2023, the Bayer Group’s three divisions asserted themselves, and in some core areas, outperformed their peers. “That’s a sign of vigor and resilience,” said CEO Bill Anderson at Friday’s virtua ...

Bayer Taps Activist Investor Jeffrey Ubben for Supervisory Board

Bayer proposes Ubben for board seat, swaps consumer unit boss

Germany's Bayer has proposed that Jeffrey Ubben, one of Wall Street's most prominent activist investors, be appointed as a non-executive director, it said on Thursday, as it announced a leadership...

Bayer Taps Ubben for Board and Changes Consumer Health Chief

(Bloomberg) — Bayer AG plans to add activist investor Jeffrey Ubben to its supervisory board in the latest shakeup at the troubled chemicals and drugs company before a capital markets event next week. Ubben, the founder of Inclusive Capital Partners in California, is one of three new independent candidates that the German company will propose…

Bayer Taps Activist Investor Jeffrey Ubben for Supervisory Board

Bayer proposes Ubben for board seat, swaps consumer unit boss

Germany's Bayer has proposed that Jeffrey Ubben, one of Wall Street's most prominent activist investors, be appointed as a non-executive director, it said on Thursday, as it announced a leadership change at its consumer products unit. The changeover comes as the diversified group faces a deluge of problems including stifling debt, U.S. litigation alleging harm from a weed-killer, a major drug development setback, weak agriculture markets and investor pressure to separate or sell businesses. Ubben, who is a member of Bayer's sustainability council, has been among a number of investors who have long urged the company to consider a break-up, but he has kept a low profile.

Bayer proposes Ubben for board seat, swaps consumer unit boss

Bayer proposes Ubben for board seat, swaps consumer unit boss

By Ludwig Burger FRANKFURT (Reuters) - Germany's Bayer has proposed that Jeffrey Ubben, one of Wall Street's most prominent activist investors, be ...

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good morning and welcome to Syros Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] This call is being webcast live on the Investors and Media section of Syros’ website at www.syros.com. Please be advised that today’s call is being recorded. […]

Syros Reports Third Quarter 2023 Financial Results and Provides a Corporate Update